Chronic Hepatitis C, Insulin Resistance and Vascular Disease

被引：6

作者：

Trpkovic, Andreja ^{[1
]}

Stokic, Edith ^{[2
]}

Radak, Djordje ^{[3
,4
]}

Gluvic, Zoran ^{[5
]}

Haidara, Mohamed ^{[6
]}

Mikhailidis, Dimitri P. ^{[7
]}

Isenovic, Esma. R. ^{[1
]}

机构：

[1] Inst Vinca, Lab Mol Genet & Radiobiol, Belgrade 11001, Serbia

[2] Inst Internal Med, Dept Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia

[3] Dedinje Cardiovasc Inst, Dept Vasc Surg, Belgrade, Serbia

[4] Univ Belgrade, Sch Med, Belgrade, Serbia

[5] Univ Hosp Zemun, Dept Endocrinol, Belgrade, Serbia

[6] King Khalid Univ, Coll Med, Dept Physiol, Abha, Saudi Arabia

[7] UCL, Sch Med, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England

来源：

CURRENT PHARMACEUTICAL DESIGN | 2010年 / 16卷 / 34期

关键词：

Hepatitis C; insulin resistance; interferon-alpha; vascular disease; PEGINTERFERON PLUS RIBAVIRIN; ACTIVATED-RECEPTOR-ALPHA; CHRONIC VIRAL-HEPATITIS; PROTEIN PHOSPHATASE 2A; FATTY LIVER-DISEASE; DEPENDENT DIABETES-MELLITUS; NECROSIS-FACTOR RECEPTORS; INDEPENDENT RISK-FACTOR; VIRUS CORE PROTEIN; COMBINATION THERAPY;

D O I：

10.2174/138161210794455067

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The role of hepatitis C virus (HCV) infection in the development of vascular disease is controversial. Insulin resistance (IR) is a recognized risk factor for cardiovascular disease (CVD) and is associated with chronic hepatitis C (CHC). Thus, IR may promote atherosclerosis and vascular disease in CHC patients. HCV-associated IR may also cause hepatic steatosis and resistance to antiviral treatment. In addition, HCV may contribute a direct, proatherogenetic action on the vascular wall. This review considers the impact of IR on interferon-based therapy of HCV infection and the role of insulin-sensitizing agents on the response to antiviral treatment and prevention of IR complications, including CVD.

引用

页码：3823 / 3829

页数：7

共 50 条

[41] Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
Fartoux, L
Poujol-Robert, A
Guéchot, J
Wendum, D
Poupon, R
Serfaty, L
GUT, 2005, 54 (07) : 1003 - 1008
[42] Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus
Shawky, M. A.
Mohammed, A. Q.
Hassan, A. M.
Ali, B. H.
Moustafa, H. M.
REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2020, 85 (02): : 173 - 179
[43] Insulin Resistance and Chronic Hepatitis C: Relationship With Serum Iron and Hepcidin
Ul Qamar, Misbah
Gill, Maria
Ikram, Faiza
Naz, Shaheena
Sadaf, Hina
Hafeez, Zobiah
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
[44] THE ASSOCIATION BETWEEN LIPID PROFILE, INSULIN RESISTANCE AND CHRONIC HEPATITIS C
Dai, C. -Y.
JOURNAL OF HEPATOLOGY, 2011, 54 : S453 - S453
[45] Insulin resistance in non-diabetic patients of chronic Hepatitis C
Kiran, Zareen
Zuberi, Bader Faiyaz
Anis, Daniah
Qadeer, Rashid
Hassan, Khalid
Afsar, Salahuddin
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (01) : 201 - 204
[46] Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection
Hung, Chao-Hung
Wang, Jing-Houng
Hu, Tsung-Hui
Chen, Chien-Hung
Chang, Kuo-Chin
Yen, Yi-Hao
Kuo, Yuan-Hung
Tsai, Ming-Chao
Lu, Sheng-Nan
Lee, Chuan-Mo
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (18) : 2265 - 2271
[47] Insulin resistance influences hepatic inflammation in patients with chronic hepatitis C
Ario, Keisuke
Mizuta, Toshihiko
Eguchi, Yuichiro
Kumagai, Takanori
Yasmake, Tsutomu
Ozaki, Iwata
Fujimoto, Kazuma
GASTROENTEROLOGY, 2006, 130 (04) : A769 - A770
[48] Chronic hepatitis C infection and insulin resistance: two best friends
Abenavoli, Ludovico
Almasio, Piero L.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (08) : 555 - 558
[49] Gamma-glutamyltransferase activity and insulin resistance in chronic hepatitis C
Gentilcore, E.
Bugianesi, E.
DIGESTIVE AND LIVER DISEASE, 2009, 41 (08) : 553 - 554
[50] Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease
Pais, Raluca
Rusu, Elena
Zilisteanu, Diana
Circiumaru, Alexandra
Micu, Laurentiu
Voiculescu, Mihai
Poynard, Thierry
Ratziu, Vlad
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (01) : 30 - 36

← 1 2 3 4 5 →